Can oxygen therapy ease long-COVID fatigue? new study watches closely
NCT ID NCT06118138
First seen Apr 21, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study followed 60 adults with ME/CFS (chronic fatigue syndrome) after COVID or other infections who chose to try hyperbaric oxygen therapy (HBOT). Participants filled out health questionnaires to track changes in physical function and fatigue over time. The goal was not to prove HBOT works, but to gather detailed observations that could help design future, more rigorous trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-COVID ME/CFS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.